Unverified50% confidenceFactExact time
Historically, credit rating agencies in the financial industry and pay-to-review systems in drug approval have been criticized for similar structural problems.
1
Sources
50%
Confidence
Long-term
Relevance
9/16/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedProvability is almost a hard requirement in regulated industries such as finance and healthcare63% similarUnverifiedCritics point out that reusing review comments may lead to the problem of "one bad review, repeated suffering across multiple venues."63% similarUnverifiedMajor criticisms of RSPs from the industry include doubts about the reliability of evaluation methods, insufficient scientific basis for threshold setting, and whether corporate self-regulation carries sufficient credible commitment.61% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/927792API
curl https://kongchang.com/api/v1/knowledge/claims/927792MCP
get_claim(id=927792)